Telix Launches New Prostate Cancer Imaging Agent, Gozellix, in U.S.
Go back to Telix Launches New Prostate Cancer Imaging Agent, Gozellix, in U.S.| TRANS-LUX CORPORATION (NASDAQ: TLX) | Delayed: 11.02 -0.32 (2.82%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.34 | 52 Week High | $2.18 | |||
| Open | $11.23 | 52 Week Low | $0.30 | |||
| Day High | $11.23 | P/E | N/A | |||
| Day Low | $11.00 | EPS | $-3.32 | |||
| Volume | 96,027 | |||||
| TRANS-LUX CORPORATION (NASDAQ: TLX) | Delayed: 11.02 -0.32 (2.82%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.34 | 52 Week High | $2.18 | |||
| Open | $11.23 | 52 Week Low | $0.30 | |||
| Day High | $11.23 | P/E | N/A | |||
| Day Low | $11.00 | EPS | $-3.32 | |||
| Volume | 96,027 | |||||

